SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-020279
Filing Date
2020-09-25
Accepted
2020-09-25 17:25:44
Documents
6
Period of Report
2020-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20200925_8k.htm 8-K 41522
2 EXHIBIT 1.1 ex_205102.htm EX-1.1 417559
3 EXHIBIT 3.1 ex_205103.htm EX-3.1 23663
4 EXHIBIT 4.4.1 ex_205105.htm EX-4.41 102610
5 EXHIBIT 99.1 ex_205104.htm EX-99.1 12426
6 a1.jpg GRAPHIC 7683
  Complete submission text file 0001437749-20-020279.txt   610066
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 201201082
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences